Orchestra BioMed Inc. (OBIO)
NASDAQ: OBIO
· Real-Time Price · USD
3.46
0.08 (2.37%)
At close: Jun 17, 2025, 12:47 PM
2.37% (1D)
| Bid | 3.41 |
| Market Cap | 132.37M |
| Revenue (ttm) | 2.89M |
| Net Income (ttm) | -66.32M |
| EPS (ttm) | -1.77 |
| PE Ratio (ttm) | -1.95 |
| Forward PE | -1.75 |
| Analyst | Buy |
| Ask | 3.49 |
| Volume | 191,402 |
| Avg. Volume (20D) | 403,220 |
| Open | 3.36 |
| Previous Close | 3.38 |
| Day's Range | 3.23 - 3.48 |
| 52-Week Range | 2.37 - 8.87 |
| Beta | 0.63 |
About OBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+10.94%
Orchestra BioMed shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
+0.7%
Orchestra BioMed shares are trading higher after the company announced it secured FDA Breakthrough Device Designation for AVIM therapy.
2 weeks ago · seekingalpha.com
Orchestra BioMed: Two Best-In-Class Devices And Promising PartnershipsOrchestra BioMed holds two best-in-class medical device therapies targeting large markets, with strong partnerships and equity investments from Medtronic and Terumo. Both AVIM Therapy and Virtue SAB h...
